Global Amiodarone Market Growth 2018-2023
Published On: November 2018
 
Report ID:355686
 
 
Pages: 136




Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.

According to this study, over the next five years the Amiodarone market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Amiodarone business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amiodarone market by product type, application, key manufacturers and key regions and countries.

This study considers the Amiodarone value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.

Tablet

Capsule

Injection

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.

Cardiac Arrest

Ventricular Tachycardia

Atrial Fibrillation

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Sanofi

Sawai Pharmaceutical

Wyeth Pharmaceuticals (Pfizer)

Mylan Pharmaceuticals

Arrow Pharma Pty Ltd

Roemmers

Cipla Pharmaceutical

Shanghai Pharmaceuticals

North China Pharmaceutical Company

Harbin Pharmaceutical Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Amiodarone consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Amiodarone market by identifying its various subsegments.

Focuses on the key global Amiodarone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Amiodarone with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Amiodarone submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Amiodarone Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Amiodarone Consumption 2013-2023

2.1.2 Amiodarone Consumption CAGR by Region

2.2 Amiodarone Segment by Type

2.2.1 Tablet

2.2.2 Capsule

2.2.3 Injection

2.3 Amiodarone Consumption by Type

2.3.1 Global Amiodarone Consumption Market Share by Type (2013-2018)

2.3.2 Global Amiodarone Revenue and Market Share by Type (2013-2018)

2.3.3 Global Amiodarone Sale Price by Type (2013-2018)

2.4 Amiodarone Segment by Application

2.4.1 Cardiac Arrest

2.4.2 Ventricular Tachycardia

2.4.3 Atrial Fibrillation

2.4.4 Others

2.5 Amiodarone Consumption by Application

2.5.1 Global Amiodarone Consumption Market Share by Application (2013-2018)

2.5.2 Global Amiodarone Value and Market Share by Application (2013-2018)

2.5.3 Global Amiodarone Sale Price by Application (2013-2018)

3 Global Amiodarone by Players

3.1 Global Amiodarone Sales Market Share by Players

3.1.1 Global Amiodarone Sales by Players (2016-2018)

3.1.2 Global Amiodarone Sales Market Share by Players (2016-2018)

3.2 Global Amiodarone Revenue Market Share by Players

3.2.1 Global Amiodarone Revenue by Players (2016-2018)

3.2.2 Global Amiodarone Revenue Market Share by Players (2016-2018)

3.3 Global Amiodarone Sale Price by Players

3.4 Global Amiodarone Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Amiodarone Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Amiodarone Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Amiodarone by Regions

4.1 Amiodarone by Regions

4.1.1 Global Amiodarone Consumption by Regions

4.1.2 Global Amiodarone Value by Regions

4.2 Americas Amiodarone Consumption Growth

4.3 APAC Amiodarone Consumption Growth

4.4 Europe Amiodarone Consumption Growth

4.5 Middle East & Africa Amiodarone Consumption Growth

5 Americas

5.1 Americas Amiodarone Consumption by Countries

5.1.1 Americas Amiodarone Consumption by Countries (2013-2018)

5.1.2 Americas Amiodarone Value by Countries (2013-2018)

5.2 Americas Amiodarone Consumption by Type

5.3 Americas Amiodarone Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Amiodarone Consumption by Countries

6.1.1 APAC Amiodarone Consumption by Countries (2013-2018)

6.1.2 APAC Amiodarone Value by Countries (2013-2018)

6.2 APAC Amiodarone Consumption by Type

6.3 APAC Amiodarone Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Amiodarone by Countries

7.1.1 Europe Amiodarone Consumption by Countries (2013-2018)

7.1.2 Europe Amiodarone Value by Countries (2013-2018)

7.2 Europe Amiodarone Consumption by Type

7.3 Europe Amiodarone Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Amiodarone by Countries

8.1.1 Middle East & Africa Amiodarone Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Amiodarone Value by Countries (2013-2018)

8.2 Middle East & Africa Amiodarone Consumption by Type

8.3 Middle East & Africa Amiodarone Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Amiodarone Distributors

10.3 Amiodarone Customer

11 Global Amiodarone Market Forecast

11.1 Global Amiodarone Consumption Forecast (2018-2023)

11.2 Global Amiodarone Forecast by Regions

11.2.1 Global Amiodarone Forecast by Regions (2018-2023)

11.2.2 Global Amiodarone Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Amiodarone Forecast by Type

11.8 Global Amiodarone Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Company Details

12.1.2 Amiodarone Product Offered

12.1.3 Sanofi Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Sanofi News

12.2 Sawai Pharmaceutical

12.2.1 Company Details

12.2.2 Amiodarone Product Offered

12.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Sawai Pharmaceutical News

12.3 Wyeth Pharmaceuticals (Pfizer)

12.3.1 Company Details

12.3.2 Amiodarone Product Offered

12.3.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Wyeth Pharmaceuticals (Pfizer) News

12.4 Mylan Pharmaceuticals

12.4.1 Company Details

12.4.2 Amiodarone Product Offered

12.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Mylan Pharmaceuticals News

12.5 Arrow Pharma Pty Ltd

12.5.1 Company Details

12.5.2 Amiodarone Product Offered

12.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Arrow Pharma Pty Ltd News

12.6 Roemmers

12.6.1 Company Details

12.6.2 Amiodarone Product Offered

12.6.3 Roemmers Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Roemmers News

12.7 Cipla Pharmaceutical

12.7.1 Company Details

12.7.2 Amiodarone Product Offered

12.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 Cipla Pharmaceutical News

12.8 Shanghai Pharmaceuticals

12.8.1 Company Details

12.8.2 Amiodarone Product Offered

12.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.8.4 Main Business Overview

12.8.5 Shanghai Pharmaceuticals News

12.9 North China Pharmaceutical Company

12.9.1 Company Details

12.9.2 Amiodarone Product Offered

12.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.9.4 Main Business Overview

12.9.5 North China Pharmaceutical Company News

12.10 Harbin Pharmaceutical Group

12.10.1 Company Details

12.10.2 Amiodarone Product Offered

12.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue, Price and Gross Margin (2016-2018)

12.10.4 Main Business Overview

12.10.5 Harbin Pharmaceutical Group News

13 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.